Bioxyne Limited / Fundamentals
Income statement
- Net revenue
€14.45M - Cost of goods sold
€9.67M - Gross profit
€4.78M - SG&A expenses
€4.15M - R&D expenses
€288.19K - EBITDA
-€6.23M - D&A
€53.19K - EBIT
€350.22K - Interest expenses
€0.00 - EBT
-€6.47M - Tax expenses
€363.01K - Net income
-€6.72M
Cash flow statement
- Net deferred tax
€396.24K - Non-cash items
€5.50M - Changes in working capital
-€846.94K - Operating cash flow
-€594.78K - Capex
€860.16K - Other investing cash flow
-€734.80K - Net investing cash flow
€653.20K - Total cash dividends paid
€0.00 - Issuance of common stock
€754.82K - Debt repayment
€72.78K - Other financing cash flow
€809.08K - Net financing cash flow
€2.80M - Foreign exchange effects
-€57.59K - Net change in cash
-€48.38K - Cash at end of period
€1.50M - Free cash flow
€265.38K
Balance sheet
- Cash and cash equivalents
€1.50M - Cash and short-term investments
€1.50M - Total receivables
€1.26M - Inventory
€2.05M - Other current assets
€1.71M - Total current assets
€6.52M - Property, plant & equipment
€1.69M - Goodwill
€0.00 - Intangible assets
€0.00 - Long-term investments
€0.00 - Other non-current assets
€132.54K - Total non-current assets
€1.82M - Total assets
€8.35M - Accounts payable
€1.71M - Short-term debt
€243.74K - Other current liabilities
€1.83M - Total current liabilities
€3.78M - Long-term debt
€725.33K - Deferred tax liabilities
€0.00 - Other non-current liabilities
€0.00 - Total non-current liabilities
€725.33K - Total liabilities
€4.51M - Common stock
€10.64M - Retained earnings
-€6.89M - Other equity
€279.90K - Total equity
€3.84M - Total liabilities and shareholders' equity
€8.35M
Company information
- Market capitalization
€48.51M - Employees
16 - Enterprise Value
€66.16M
Company ratios
- Gross margin
-
33.1% Much worse than peer group: 81.9% - EBITDA margin
-
-43.1% Much better than peer group: -10,704.2% - EBIT margin
-
2.4% Much better than peer group: -12,146.5% - EBT margin
-
-44.8% Much better than peer group: -10,160.9% - Net margin
-
-46.5% Much better than peer group: -9,858.7% - ROE
-
-174.8% Much worse than peer group: 323.5% - ROA
-
-80.5% Much better than peer group: -105.9% - Asset turnover
-
173.1% Much better than peer group: 63.6% - FCF margin
-
-10.1% Much better than peer group: -3,745.3% - FCF yield
-3.0% - Efficiency ratio
143.1% - Net sales per employee
-
€903.12K - Net income per employee
-
-€419.72K